Ventora Medical closes investment round during COVID19.

MedTech Actuator startup Ventora Medical has successfully closed its angel investment round in the midst of the COVID19 global pandemic. The new investment will make it possible for Ventora Medical to advance their technology that helps premature babies to breathe.

Backed by the Walker Group and MedTech ActuatorTM partner Artesian, this latest capital raise has attracted coverage in The Australian Business Review, the Herald Sun and AusBiz StartUp Daily, and brings their total funding to date to $1.25M.

The new round will allow the team to deliver crucial work including a preclinical study in late 2020 with the Medical Device Partnering Program, a clinical pilot study in early 2021 and further development of an alpha prototype.

The breathing support that clinicians give to babies born prematurely plays a critical role in their survival, length of stay in neonatal intensive care and long-term health. Ventora Medical’s continuous airway pressure monitoring device will help clinicians to administer this vital breathing support with greater precision.

Non-invasive breathing support methods are designed to help babies breathe by keeping their lungs inflated. However, due to unaccounted for leaks in the system, there is no way of knowing the actual pressure being delivered to the lungs. Clinicians must therefore rely on clinical signs and symptoms when setting the pressure, which can often be delayed and confusing.

Ventora Medical’s device will make this process easier, improve the accuracy of breathing support, reduce the incidence and impact of further breathing complications, and save hospitals time and money by reducing the patient’s length of stay.

To learn more about Ventora Medical and follow their journey visit www.ventoramedical.com.

MedTech Actuator Menzies Scholarships now open

Applications are now open for 2021 MedTech Actuator Menzies Scholarships – each valued at $10,000. Ten junior researchers will each receive tailored education, access to exclusive industry events and a $1,000 stipend to support them in exploring their commercialisation goals.

Scholarships are available to high-potential junior health, medical or biotechnology scientists and researchers who may be undertaking their honours, masters or PhD – or even starting to work in their chosen field.

The three-month scholarship will run from February to April 2021 and can be undertaken remotely while studying and working – requiring a small time commitment in month one and two and attendance at a three day immersion intensive during month three.

Scholarship recipients will experience unparalleled networking opportunities and gain insights into the possibilities in a career that fuses science, research, and entrepreneurship.

Scholarship recipients will complete their immersion intensive and online learning alongside Asia Pacific’s best emerging entrepreneurs competing in the MedTech Actuator Origin international pitch competition. In the final month of the scholarship, recipients will see the entrepreneurs pitch in MedTech Actuator Origin Rapid Fire Rounds and Gala Finals and network with the largest names in global MedTech corporates, clinicians, ecosystem VIPs and investors.

Beyond these unique insights and networking opportunities, the immersion intensive and online course will provide scholarship recipients with a strong foundation in commercialisation. Topics will include intellectual property, pitching, startup 101, finance for beginners, business modelling, design thinking, path-to-market, and market analysis.

The MedTech Actuator Menzies Scholarship will support the scientific community’s commercialisation capacity by facilitating knowledge transfer from industry to junior scientists and researchers.

If you are a junior scientist or researcher – or you know one – you can find out more about the scholarship and apply here.

The MedTech Actuator Menzies Scholarship is supported by the Menzies Foundation as part of their Entrepreneurship in Science mission in partnership with the MedTech Actuator.

Apply now